Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01661972
Title Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors John Strickler, M.D.
Indications

colorectal cancer

Advanced Solid Tumor

Therapies

Aflibercept + Capecitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.